BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ghazavi H, Hoseini SJ, Ebrahimzadeh-Bideskan A, Mashkani B, Mehri S, Ghorbani A, Sadri K, Mahdipour E, Ghasemi F, Forouzanfar F, Hoseini A, Pasdar AR, Sadeghnia HR, Ghayour-Mobarhan M. Fibroblast Growth Factor Type 1 (FGF1)-Overexpressed Adipose-Derived Mesenchaymal Stem Cells (AD-MSCFGF1) Induce Neuroprotection and Functional Recovery in a Rat Stroke Model. Stem Cell Rev Rep 2017;13:670-85. [PMID: 28795363 DOI: 10.1007/s12015-017-9755-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Forouzanfar F, Ebrahimi PR, Sadeghnia HR. Neuroprotection of everolimus against focal cerebral ischemia-reperfusion injury in rats. J Stroke Cerebrovasc Dis 2022;31:106576. [PMID: 35633587 DOI: 10.1016/j.jstrokecerebrovasdis.2022.106576] [Reference Citation Analysis]
2 Li M, Department of Geriatrics, Department of Integrated Traditional Chinese and Western Medicine, Shaoxing People’ s hospital, Shaoxing 312000, China. Progress on the study of fibroblast growth factors as novel therapeutics in post-stroke cognitive impairment. APT 2021;3:48-55. [DOI: 10.31491/apt.2021.09.065] [Reference Citation Analysis]
3 Bagdasarian FA, Yuan X, Athey J, Bunnell BA, Grant SC. NODDI highlights recovery mechanisms in white and gray matter in ischemic stroke following human stem cell treatment. Magn Reson Med 2021. [PMID: 34355818 DOI: 10.1002/mrm.28929] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Forouzanfar F, Sadeghnia HR. Fibroblast Growth Factors as Tools in the Management of Neuropathic Pain Disorders. Curr Drug Targets 2020;21:1034-43. [PMID: 32324511 DOI: 10.2174/1389450121666200423084205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Li F, Zhu S, Jiang Q, Hou C, Pang T, Zhang L, Li W. Novel Stachydrine-Leonurine Conjugate SL06 as a Potent Neuroprotective Agent for Cerebral Ischemic Stroke. ACS Chem Neurosci 2021;12:2478-90. [PMID: 34180238 DOI: 10.1021/acschemneuro.1c00200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Guo Y, Peng Y, Zeng H, Chen G. Progress in Mesenchymal Stem Cell Therapy for Ischemic Stroke. Stem Cells Int 2021;2021:9923566. [PMID: 34221026 DOI: 10.1155/2021/9923566] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
7 Asgharzade S, Talaei A, Farkhondeh T, Forouzanfar F. Combining Growth Factor and Stem Cell Therapy for Stroke Rehabilitation, A Review. Curr Drug Targets 2020;21:781-91. [PMID: 31914912 DOI: 10.2174/1389450121666200107100747] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
8 Salehi MS, Safari A, Pandamooz S, Jurek B, Hooshmandi E, Owjfard M, Bayat M, Zafarmand SS, Miyan JA, Borhani-Haghighi A. The Beneficial Potential of Genetically Modified Stem Cells in the Treatment of Stroke: a Review. Stem Cell Rev Rep 2021. [PMID: 34033001 DOI: 10.1007/s12015-021-10175-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Forouzanfar F, Shojapour M, Aghili ZS, Asgharzade S. Growth Factors as Tools in Photoreceptor Cell Regeneration and Vision Recovery. Curr Drug Targets 2020;21:573-81. [PMID: 31755378 DOI: 10.2174/1389450120666191121103831] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Xia J, Arai S, Haider KH. Researches and Applications of Stem Cell Secretome. Stem cells: From Potential to Promise 2021. [DOI: 10.1007/978-981-16-0301-3_7] [Reference Citation Analysis]
11 Lee S, Kim OJ, Lee KO, Jung H, Oh SH, Kim NK. Enhancing the Therapeutic Potential of CCL2-Overexpressing Mesenchymal Stem Cells in Acute Stroke. Int J Mol Sci 2020;21:E7795. [PMID: 33096826 DOI: 10.3390/ijms21207795] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
12 Zhang S, Lachance BB, Moiz B, Jia X. Optimizing Stem Cell Therapy after Ischemic Brain Injury. J Stroke 2020;22:286-305. [PMID: 33053945 DOI: 10.5853/jos.2019.03048] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
13 Yousefifard M, Shamseddin J, Babahajian A, Sarveazad A. Efficacy of adipose derived stem cells on functional and neurological improvement following ischemic stroke: a systematic review and meta-analysis. BMC Neurol 2020;20:294. [PMID: 32778066 DOI: 10.1186/s12883-020-01865-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
14 Li J, Zhang Q, Wang W, Lin F, Wang S, Zhao J. Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential. J Neurol. [DOI: 10.1007/s00415-020-10138-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
15 Acosta SA, Lee JY, Nguyen H, Kaneko Y, Borlongan CV. Endothelial Progenitor Cells Modulate Inflammation-Associated Stroke Vasculome. Stem Cell Rev Rep 2019;15:256-75. [PMID: 30739275 DOI: 10.1007/s12015-019-9873-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 13.5] [Reference Citation Analysis]
16 Talaei A, Farkhondeh T, Forouzanfar F. Fibroblast Growth Factor: Promising Target for Schizophrenia. Curr Drug Targets 2020;21:1344-53. [PMID: 32598256 DOI: 10.2174/1389450121666200628114843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Filippenkov IB, Stavchansky VV, Denisova AE, Yuzhakov VV, Sevan'kaeva LE, Sudarkina OY, Dmitrieva VG, Gubsky LV, Myasoedov NF, Limborska SA, Dergunova LV. Novel Insights into the Protective Properties of ACTH(4-7)PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia-Reperfusion in Rats. Genes (Basel) 2020;11:E681. [PMID: 32580520 DOI: 10.3390/genes11060681] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
18 Zhang L, Li F, Hou C, Zhu S, Zhong L, Zhao J, Song C, Li W. Design, synthesis, and biological evaluation of novel stachydrine derivatives as potent neuroprotective agents for cerebral ischemic stroke. Naunyn-Schmiedeberg's Arch Pharmacol 2020;393:2529-42. [DOI: 10.1007/s00210-020-01868-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
19 Cunningham CJ, Wong R, Barrington J, Tamburrano S, Pinteaux E, Allan SM. Systemic conditioned medium treatment from interleukin-1 primed mesenchymal stem cells promotes recovery after stroke. Stem Cell Res Ther. 2020;11:32. [PMID: 31964413 DOI: 10.1186/s13287-020-1560-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
20 Arteaga Cabeza O, Mikrogeorgiou A, Kannan S, Ferriero DM. Advanced nanotherapies to promote neuroregeneration in the injured newborn brain. Adv Drug Deliv Rev 2019;148:19-37. [PMID: 31678359 DOI: 10.1016/j.addr.2019.10.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
21 Forouzanfar F, Shojapour M, Asgharzade S, Amini E. Causes and Consequences of MicroRNA Dysregulation Following Cerebral Ischemia-Reperfusion Injury. CNSNDDT 2019;18:212-21. [DOI: 10.2174/1871527318666190204104629] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
22 Huynh MB, Ouidja MO, Chantepie S, Carpentier G, Maïza A, Zhang G, Vilares J, Raisman-Vozari R, Papy-Garcia D. Glycosaminoglycans from Alzheimer's disease hippocampus have altered capacities to bind and regulate growth factors activities and to bind tau. PLoS One 2019;14:e0209573. [PMID: 30608949 DOI: 10.1371/journal.pone.0209573] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 9.7] [Reference Citation Analysis]
23 Zhang Y, Yu S, Tuazon JP, Lee JY, Corey S, Kvederis L, Kingsbury C, Kaneko Y, Borlongan CV. Neuroprotective effects of human bone marrow mesenchymal stem cells against cerebral ischemia are mediated in part by an anti-apoptotic mechanism. Neural Regen Res 2019;14:597-604. [PMID: 30632499 DOI: 10.4103/1673-5374.247464] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
24 Forouzanfar F, Vahedi MM, Aghaei A, Rakhshandeh H. Hydroalcoholic Extract of Cuscuta Epithymum Enhances Pentobarbitalinduced Sleep: Possible Involvement of GABAergic System. Curr Drug Discov Technol 2020;17:332-7. [PMID: 30394211 DOI: 10.2174/1570163815666181105091801] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
25 Dergunova LV, Filippenkov IB, Stavchansky VV, Denisova AE, Yuzhakov VV, Mozerov SA, Gubsky LV, Limborska SA. Genome-wide transcriptome analysis using RNA-Seq reveals a large number of differentially expressed genes in a transient MCAO rat model. BMC Genomics 2018;19:655. [PMID: 30185153 DOI: 10.1186/s12864-018-5039-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
26 Forouzanfar F, Butler AE, Banach M, Barreto GE, Sahbekar A. Modulation of heat shock proteins by statins. Pharmacological Research 2018;134:134-44. [DOI: 10.1016/j.phrs.2018.06.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
27 Cunningham CJ, Redondo-Castro E, Allan SM. The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke. J Cereb Blood Flow Metab. 2018;38:1276-1292. [PMID: 29768965 DOI: 10.1177/0271678x18776802] [Cited by in Crossref: 124] [Cited by in F6Publishing: 134] [Article Influence: 31.0] [Reference Citation Analysis]
28 Forouzanfar F, Sadeghnia HR, Hoseini SJ, Ghorbani A, Ghazavi H, Ghasemi F, Hosseinzadeh H. Fibroblast Growth Factor 1 Gene-Transfected Adipose-Derived Mesenchymal Stem Cells Modulate Apoptosis And Inflammation In The Chronic Constriction Injury Model of Neuropathic Pain. Iran J Pharm Res 2020;19:151-9. [PMID: 33841531 DOI: 10.22037/ijpr.2020.113223.14176] [Reference Citation Analysis]